4.4 Article

Geographic Expansion of Lyme Disease in the Southeastern United States, 2000-2014

Journal

OPEN FORUM INFECTIOUS DISEASES
Volume 2, Issue 4, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofv143

Keywords

Lyme disease; epidemiology; GIS; North Carolina; Virginia

Funding

  1. National Center for Advancing Translational Sciences of the National Institutes of Health [KL2 TR001115]
  2. Ken and Sherrilyn Fisher Center for Environmental Infectious Diseases
  3. National Institute for Allergy and Infectious Diseases of the National Institutes of Health [K24 AI093969]
  4. Boston Children's Hospital Pilot research grant
  5. Thomas F. and Kate Miller Jeffress Memorial Trust
  6. InterAmerican Institute for Global Change Research [CRN 3036]
  7. Cerexa
  8. Pfizer
  9. Advanced Liquid Logic
  10. MedImmune
  11. Cubist
  12. Merck
  13. Astellas
  14. Affinium
  15. Theravance
  16. Debiopharm
  17. Durata
  18. NovaDigm
  19. Novartis
  20. Medicines Company
  21. Biosynexus
  22. Inimex
  23. Directorate For Geosciences
  24. ICER [1128040] Funding Source: National Science Foundation

Ask authors/readers for more resources

Background. The majority of Lyme disease cases in the United States are acquired on the east coast between northern Virginia and New England. In recent years the geographic extent of Lyme disease has been expanding, raising the prospect of Lyme disease becoming endemic in the southeast. Methods. We collected confirmed and probable cases of Lyme disease from 2000 through 2014 from the Virginia Department of Health and North Carolina Department of Public Health and entered them in a geographic information system. We performed spatial and spatiotemporal cluster analyses to characterize Lyme disease expansion. Results. There was a marked increase in Lyme disease cases in Virginia, particularly from 2007 onwards. Northern Virginia experienced intensification and geographic expansion of Lyme disease cases. The most notable area of expansion was to the southwest along the Appalachian Mountains with development of a new disease cluster in the southern Virginia mountain region. Conclusions. The geographic distribution of Lyme disease cases significantly expanded in Virginia between 2000 and 2014, particularly southward in the Virginia mountain ranges. If these trends continue, North Carolina can expect autochthonous Lyme disease transmission in its mountain region in the coming years.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available